Category: Studies

1. Introduction: Overcoming Challenges in LDL-C Target Achievement Despite the widespread use of statins, many high- and very-high-risk cardiovascular patients fail to reach their strict LDL-C goals due to treatment limits or statin intolerance. Managing dyslipidemia effectively often requires addressing both endogenous cholesterol production and intestinal absorption simultaneously. Bempo Plus, manufactured by Zein Pharma, combines...

1. Introduction: Addressing the Dual Challenge of Male LUTS/BPH Lower Urinary Tract Symptoms associated with Benign Prostatic Hyperplasia (LUTS/BPH) are broadly divided into two clinical components: Voiding Symptoms: Poor stream, hesitancy, straining, and terminal dribbling caused by bladder outlet obstruction. Storage (Irritative) Symptoms: Urgency, increased daytime frequency, urgency urinary incontinence (UUI), and nocturia. While α1​-blocker monotherapy...

1. Introduction: The Evolution of Acid Suppression Therapy For decades, Proton Pump Inhibitors (PPIs) have represented the standard of care for acid-related gastrointestinal disorders. However, real-world clinical data highlights persistent therapeutic gaps: Persistent Symptoms: In survey data of patients on daily PPI regimens, approximately 54% reported persistent reflux symptoms. High Recurrence: Up to 80% of...